Summary
Comparison of 7-hydroxylation of coumarin, a CYP2A6 substrate, in human and African green and cynomolgus monkey liver microsomes was made by means of an HPLC assay with UV detection. In human liver microsomes, the Km and Vmax values for the metabolic conversion were 2.1 μM and 0.79 nmol/mg/min, respectively. While African green monkey showed Km and Vmax values of 2.7 μM and 0.52 nmol/mg/min, which were similar to human, higher Km and Vmax values were found in cynomolgus monkey. Coumarin 7-hydroxylation in human and African green monkey was selectively inhibited by methoxsalen and pilocarpine (CYP2A6 inhibitors) but not by other inhibitors, i.e. α-naphthoflavone (CYP1A1), orphenadrine (CYP2B6), sulfaphenazole (CYP2C9), quinidine (CYP2D6) and ketoconazole (CYP3A4). Immunoinhibition results supported CYP2A6 involvement in human and its homolog in monkey in coumarin 7-hydroxylation, as only anti-CYP2A6, but not CYP2B1, CYP2C13, CYP2D6, CYP2E1 or CYP3A antibodies, inhibited this conversion. African green monkey was found to be similar to human in catalytic activity of coumarin 7-hydroxylation and response to CYP2A6 inhibitors or antibody inhibition. However, the monkey CYP2A6 is not identical to the human in that Ki values were different, and differences were observed with some CYP2A6 inhibitors, such as nicotine and methoxsalen, suggesting that, under some circumstances, studies of nicotine kinetics and drug taking behavior in monkey may not be comparable to human.
Similar content being viewed by others
References
Cashman J.R., Park S.B., Yang Z-C., Wrighton S.A., Jacob III P., Benowitz N.L. (1992): Metabolism of nicotine by human liver microsomes: stereoselective formation of trans-nicotine N′-oxide. Chem. Res. Toxicol., 5, 639–646.
McCracken N.W., Cholerton S., Idle J.R. (1992): Cotinine formation by cDNA-expressed human cytochrome P450. Med. Sci. Res., 20, 877–878.
Messina E.S., Tyndale R.F., Sellers E.M. (1997): A major role for CYP2A6 in nicotine C-oxidation by human liver microsome. J. Pharmacol. Exp. Ther., In press.
Fernandez-Salguero P., Gonzalez F.J. (1995): The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics, 5, S123-S128.
Yamano S., Tatsuno J., Gonzalez F.J. (1990): The CYP2A3 gene product catalyzes coumarin 7-hydroxylation in human liver microsomes. Biochemistry, 29, 1322–1329.
Miles J.S., McLaren A.W., Forrester L.M., Glancey M.J., Lang M.A., Wolf C.R. (1990): Identification of the human liver cytochrome P450 responsible for coumarin 7-hydroxylase activity. Biochem. J., 267, 365–371.
Yun C-H., Shimada T., Guengerich F.P. (1991): Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol. Pharmacol., 40, 679–685.
Dalet-Beluche I., Boulenc X., Fabre G., Maurel P., Bonfils C. (1992): Purification of two cytochrome P450 isozymes related to CYP2A and CYP3A heme families from monkey (baboon,Papio papio) liver microsomes. Cross reactivity with human forms. Eur. J. Biochem., 204, 641–648.
Pearce R., Greenway D., Parkinson A. (1992): Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch. Biochem. Biophys., 298, 211–225.
Pelkonen O., Sotaniemi E.A., Ahokas J.T. (1985): Coumarin 7-hydroxylase activity in human liver microsomes. Properties of the enzyme and interspecies comparisons. Br. J. Clin. Pharmacol., 19, 59–66.
Lake B.G., Gaudin H., Price R.J., Walters D.G. (1992): Metabolism of [3-14C] coumarin to polar and covalently bound products by hepatic microsomes from the rat, Syrian hamster, gerbil and humans. Fed. Chem. Toxicol., 30, 105–115.
Stevens J.C., Shipley L.A., Cashman J.R., Vandenbranden M., Wrighton S.A. (1993): Comparison of human and rhesus monkey in vitro phase I and phase II hepatic drug metabolism activities. Drug Metab. Dispos., 21, 753–760.
Steensma A., Beamand J.A., Walters D.G., Price R.J., Lake B.G. (1994): Metabolism of coumarin and 7-ethoxycoumarin by rat, mouse, guinea pig, cynomolgus monkey and human precision-cut liver slices. Xenobiotica, 24, 893–907.
Sharer J.E., Shipley L.A., Vandenbranden M.R., Binkley S.N., Wrighton S.A. (1995): Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey and cynomolgus monkey. Drug Metab. Dispos., 23, 1231–1241.
Ohmori S. Horie T., Guengerich F.P., Kiuchi M., Kitada M. (1993): Purification and characterization of two forms of hepatic microsomal cytochrome P450 from untreated cynomolgus monkeys. Arch. Biochem. Biophys., 305, 405–413.
Bourrie M., Meunier V., Berger Y., Fabre G. (1996): Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. J. Pharmacol. Exp. Ther., 277, 321–332.
Draper A.J., Madan A., Parkinson A. (1997): Inhibition of coumarin 7-hydroxylase activity in human liver microsomes. Arch. Biochem. Biophys., 341, 47–61.
Maenpaa J., Sigusch H., Raunio H. et al. (1993): Differential inhibition of coumarin 7-hydroxylase activity in mouse and human liver microsomes. Biochem. Pharmacol., 45, 1035–1042.
Chang T.K.H., Gonzalez F.J., Waxman D.J. (1994): Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450. Arch. Biochem. Biophys., 311, 437–442.
Guengerich F.P. (1995). Human cytochrome P450 enzymes. In: Ortiz de Montellano, Paul R. (eds) Cytochrome P450: Structure, Mechanism, and Biochemistry. New York: Plenum, 473–535.
Lake B.G., Sauer M.J., Esclangon F., Beamand J.A., Price R.J., Walters D.G. (1995): Metabolism of coumarin by precision-cut calf liver slices and calf liver microsomes. Xenobiotica, 25, 133–141.
Maenpaa J., Juvonen R., Raunio H., Rautio A., Pelkonen O. (1994): Metabolic interactions of methoxsalen and coumarin in humans and mice. 48, 1363–1369.
Raunio H., Syngelma T., Pasanen M. et al. (1988): Immunochemical and catalytic studies on hepatic coumarin 7-hydroxylase in man, rat, and mouse. Biochem. Pharmacol., 37, 3889–3895.
Kimonen T., Juvonen R. O., Alhava E., Pasenen M. (1995): The inhibition of CYP enzymes in mouse and human liver by pilocarpine. Br. J. Pharmacol., 114, 832–836.
Nakajima M., Yamamoto T., Nunoya K-I. et al. (1996): Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J. Pharmacol. Exp. Ther., 277, 1010–1015.
Nakajima M., Yamamoto T., Nunoya K-I. et al. (1996): Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab. Dispos., 24, 1212–1217.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Li, Y., Li, NY. & Sellers, E.M. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes. Eur. J. Drug Metab. Pharmacokinet. 22, 295–304 (1997). https://doi.org/10.1007/BF03190960
Issue Date:
DOI: https://doi.org/10.1007/BF03190960